Low-dose weekly supplementation of iron and/or zinc does not affect growth among Bangladeshi infants

Eur J Clin Nutr. 2009 Jan;63(1):87-92. doi: 10.1038/sj.ejcn.1602905. Epub 2007 Sep 19.

Abstract

Objectives: To determine the effect of low-dose weekly supplementation with iron, zinc or both on growth of infants from 6 to 12 months of age.

Subjects/methods: A total of 645 breastfed infants age 6 months who were not severely anemic (Hb> or = 90 g l(-1)) or severely malnourished (weight-for-age > or = 60% median) were randomized to receive 20 mg iron and 1 mg riboflavin; 20 mg zinc and 1 mg riboflavin; 20 mg iron, 20 mg zinc and 1 mg riboflavin; or riboflavin alone (control) weekly for 6 months.

Results: Baseline characteristics were similar among the four supplementation groups. Weight, length and mid-upper arm circumference were assessed at baseline, 8, 10 and 12 months of age. There was no interaction of iron and zinc when given in a combined supplement on either weight or length (P>0.05). There were no effects of either iron or zinc on the rate of length or weight gain for all infants or when stratified by baseline Hb concentration.

Conclusions: Weekly supplementation of 20 mg Fe, 20 mg Zn, or both does not benefit growth among infants 6-12 months of age in rural Bangladesh, a region with high rates of anemia and zinc deficiency.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Arm / anatomy & histology
  • Bangladesh
  • Body Height
  • Body Weight
  • Dietary Supplements*
  • Drug Therapy, Combination
  • Growth / drug effects*
  • Humans
  • Infant
  • Iron / pharmacology*
  • Riboflavin / pharmacology
  • Rural Population
  • Zinc / pharmacology*

Substances

  • Iron
  • Zinc
  • Riboflavin